Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit or (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/07/17 8-K Current report filing
Related Documents
11/06/17 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
10/13/17 424B3 Prospectus filed pursuant to Rule 424(b)(3) 100
10/12/17 EFFECT Notice of Effectiveness 1
10/10/17 UPLOAD SEC-generated letter 1
10/10/17 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
10/10/17 D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. 7
09/29/17 S-1 General form of registration statement for all companies including face-amount certificate companies
Related Documents
09/29/17 8-K Current report filing
Related Documents
09/15/17 RW Registration Withdrawal Request 1